U.S. Stock News

M&T Bank (MTB) closed out FY 2025 with fourth quarter revenue of US$2.4 billion and basic EPS of US$4.71, alongside net income of US$718 million, framing a year where the trailing 12 month tally reached US$9.2 billion of revenue and US$17.10 in EPS. Over the past few quarters, revenue has moved from US$2.2 billion in Q4 2024 to US$2.4 billion in Q4 2025, while quarterly EPS increased from US$3.88 to US$4.71, supported by higher net income. This sets up a results season in which investors are...

In early January 2026, Rapport Therapeutics announced past and planned advances across its clinical pipeline, including preparing a Phase 3 program for RAP-219 in focal onset seizures, expanding into primary generalized tonic-clonic seizures, and resuming its Phase 2 diabetic peripheral neuropathic pain trial after the FDA lifted a clinical hold. A key insight is that Rapport is concentrating resources on programs it believes can meaningfully address unmet neurological needs while supporting...

North Dallas Bank & Trust (NODB) just wrapped up FY 2025 with fourth quarter total revenue of US$12.9 million and basic EPS of US$1.19, capping a trailing twelve month stretch that sums to US$48.0 million in revenue and EPS of US$3.35. Over the past few quarters, revenue has moved from US$9.8 million in Q3 2024 to US$12.9 million in Q4 2025. Quarterly EPS has ranged from US$0.20 in Q3 2024 to US$1.19 most recently, alongside reported profit growth of 166.6% and a net profit margin that...

United Parks & Resorts recently announced that SeaWorld returned in early 2026 with an expanded coast-to-coast live music series, offering full-length concerts by artists such as Flo Rida, Boyz II Men, and The Beach Boys in Orlando, San Diego, and San Antonio at no extra cost beyond park admission. This move places live entertainment at the center of the guest experience and is designed to deepen Annual Pass value by giving members flexible, season-long access to multiple concerts across...

In Q4 2025, Select Medical Holdings Corporation disclosed spending US$630,000 on lobbying related to regulations for long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient rehabilitation clinics, with a particular focus on Medicare payment issues, while institutional investors showed mixed positioning and analysts recently issued positive ratings. This combination of targeted policy engagement and favorable analyst sentiment highlights how regulatory influence...

ICL Group was recently upgraded by Zacks to a Rank #2 (Buy) after analysts raised their earnings estimates, with the consensus forecast climbing 11.1% over the past three months, signaling a more favorable earnings outlook than previously expected. This upward revision in earnings expectations suggests analysts see improving profit potential for ICL’s specialty minerals and chemicals portfolio, which could influence how investors view the company’s longer-term business prospects and risk...

If you are wondering whether Darling Ingredients is reasonably priced or offering a margin of safety right now, this article will walk through what the current share price might be implying about its value. The stock recently closed at US$39.57, with returns of 1.3% over 7 days, 14.4% over 30 days, 5.1% year to date, 8.0% over 1 year, and a 39.7% and 40.7% decline over 3 and 5 years respectively. Taken together, these figures give mixed signals about how the market has been treating the...

StubHub Holdings (STUB) is back in focus as multiple securities class action lawsuits over its 2025 IPO disclosures approach a January 23 lead plaintiff deadline, keeping legal and cash flow questions front and center for shareholders. See our latest analysis for StubHub Holdings. Recent trading reflects elevated uncertainty, with a 7 day share price return of 25.29% and a 30 day gain of 14.37% partly offsetting a 90 day share price return of negative 6.71%. The stock is at $16.0 with year to...

Event context and recent stock performance Indivior (INDV) has been on investors’ radar after recent share price swings, with the stock showing a 1 day return of 1.05% and a 7 day decline of 8.18%. Over the past month the share price return is a 9.49% decline, contrasting with a 32.92% gain over the past 3 months. This may prompt investors to reassess how current pricing lines up with Indivior’s fundamentals. See our latest analysis for Indivior. At a share price of US$32.54, Indivior’s...

Event context for Accelerant Holdings Accelerant Holdings (ARX) has drawn investor attention after recent share price moves, with the stock showing a negative 1 day return of 2.1% and a negative 7 day return of 4.8%. Over the past month the stock posted a negative return of 4.5%. Over the past 3 months it shows a 16.4% gain, setting up a contrast that raises questions about how investors are weighing its growing revenue and current net loss. See our latest analysis for Accelerant Holdings. At...

USA Compression Partners, LP recently declared a fourth-quarter 2025 cash distribution of US$0.525 per common unit (US$2.10 annualized), payable on February 6, 2026 to unitholders of record as of January 26, 2026, and scheduled its fourth-quarter earnings release and conference call for February 17, 2026. Together with new financing agreements linked to a recent acquisition, these announcements highlight USA Compression Partners’ focus on supporting its distribution while reinforcing its...

In recent days, Scotiabank downgraded Douglas Emmett Inc. from Sector Outperform to Sector Perform, while other brokers also lowered their ratings, citing weaker office leasing and soft occupancy trends across key Los Angeles properties. This cluster of downgrades highlights how concentrated exposure to the Los Angeles Westside office market can magnify the impact of slower leasing recoveries on a single REIT. Next, we’ll examine how these analyst concerns about office leasing momentum could...

Ouster recently presented at the 28th Annual Needham Growth Conference on January 15, 2026, at The Lotte New York Palace Hotel in New York, where CEO Angus Pacala, Senior VP of Strategic Finance & Treasurer Chen Geng, and CFO Kenneth P. Gianella addressed attendees. This high-profile conference appearance gave Ouster’s leadership a platform to communicate its roadmap and capital allocation priorities directly to institutional investors and analysts. We’ll now examine how Ouster’s Needham...

Xencor (XNCR) recently outlined 2026 priorities for its XmAb platform, highlighting early clinical data for renal cell carcinoma candidate XmAb819 and setting out timelines for multiple oncology and autoimmune milestones that could influence investor expectations. See our latest analysis for Xencor. Despite the fresh 2026 pipeline update, Xencor’s recent share price momentum has been weak, with a 30 day share price return of a 19.05% decline and a 1 year total shareholder return of a 33.52%...

In mid-January 2026, High Roller Technologies, Inc. announced a binding Letter of Intent with Crypto.com | Derivatives North America to power a regulated, event-based prediction markets product in the United States, alongside multiple non-binding marketing LOIs with social-first sports media platforms to support its planned launch. A distinctive aspect of this move is High Roller’s effort to pair regulated prediction-market infrastructure with billion-scale social media reach from partners...

Hawaiian Electric Industries (HE) is back in focus after reaching preliminary agreements to settle eight shareholder lawsuits tied to wildfire risk disclosures, funded by US$100 million in insurance proceeds and accompanied by new Hawaii wildfire legislation. See our latest analysis for Hawaiian Electric Industries. The wildfire settlement progress and new Hawaii legislation arrive after a sharp rebound in sentiment, with a 20.72% 1 month share price return and a 58.10% 1 year total...

WaFd (WAFD) opened fiscal Q1 2026 with total revenue of US$187.9 million and basic EPS of US$0.79, while trailing twelve month revenue stood at US$734.5 million and EPS at US$2.89, giving investors a clear view of both the latest quarter and the broader earnings run rate. Over recent quarters, the bank has seen revenue move from US$171.1 million in Q1 2025 to US$187.9 million in Q1 2026, with quarterly EPS shifting from US$0.54 to US$0.79 across the same period, setting up this result against...

Earlier this month, Enerpac Tool Group Corp. presented at CJS Securities’ 26th Annual “New Ideas for the New Year” Investor Conference on January 14, 2026, and has since attracted fresh analyst attention. William Blair’s initiation of coverage with a “Market Perform” rating adds another professional viewpoint to existing research, potentially broadening institutional interest and debate around Enerpac’s prospects. Next, we’ll examine how William Blair’s new coverage could influence Enerpac...

If you are wondering whether Nutanix is attractively priced or just feels cheap after a rough patch, you are exactly who this breakdown is for. The stock recently closed at US$45.74, with returns of a 14.5% decline over 7 days, 8.9% decline over 30 days, 9.6% decline year to date, 29.8% decline over 1 year, but 70.7% and 36.5% gains over 3 and 5 years respectively. This points to mixed sentiment and changing expectations around the company. Recent attention on Nutanix has focused on its...

Westamerica Bancorporation (WABC) has wrapped up FY 2025 with fourth quarter revenue of US$63.3 million and basic EPS of US$1.12, alongside net income of US$27.8 million, providing a clear snapshot of its latest run rate. The bank has seen quarterly revenue shift from US$73.9 million in Q3 2024 to US$63.3 million in Q4 2025, with basic EPS moving from US$1.31 to US$1.12 over the same stretch. Trailing twelve month revenue for Q4 2025 is US$258.4 million and EPS is US$4.52. In that context,...

What Jefferson Capital’s recent trading signals tell you Recent trading in Jefferson Capital (JCAP) has drawn attention after a mixed pattern of short term declines alongside gains over the past month and past 3 months, prompting investors to reassess how its fundamentals line up with sentiment. See our latest analysis for Jefferson Capital. With the share price at $22.55, Jefferson Capital’s recent 1 day and 7 day share price declines contrast with a stronger 30 day and especially 90 day...

It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.9x right...

If you are wondering whether Occidental Petroleum is a bargain or just fairly priced at its recent US$42.70 close, you are not alone. The stock has had mixed returns, with a 5.1% gain over the last 30 days, a 0.8% return year to date, a 16.0% decline over 1 year, and a 32.9% decline over 3 years, while still sitting 110.9% above its level 5 years ago. Recent news coverage has focused on Occidental Petroleum as a major US energy name, often discussed in the context of oil price moves, capital...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...